12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of various health care stocks on Wednesday. Notable gainers include Avidity Biosciences (NASDAQ:RNA), Molecular Partners (NASDAQ:MOLN), and Longeveron (NASDAQ:LGVN). Significant losers include ThermoGenesis Holdings (NASDAQ:THMO) and Calidi Biotherapeutics (AMEX:CLDI).
June 12, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Longeveron shares rose 15.84% to $0.95 in pre-market trading, showing increased investor interest.
The price increase suggests growing investor interest, which could lead to further gains in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Molecular Partners shares increased by 18.43% to $5.91 in pre-market trading, reflecting positive market sentiment.
The substantial rise in share price indicates positive sentiment, which may continue to drive the stock upwards in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Avidity Biosciences shares rose 24.5% to $36.0 in pre-market trading, indicating strong investor interest.
The significant price increase suggests strong investor confidence, likely leading to continued positive momentum in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Calidi Biotherapeutics shares fell 11.86% to $0.24 in pre-market trading, showing negative market reaction.
The decline in share price indicates negative sentiment, which may continue to affect the stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Streamline Health Solutions shares decreased by 10.94% to $0.57 in pre-market trading following the release of their Q1 earnings report.
The drop in share price following the Q1 earnings report suggests investor disappointment, likely leading to continued negative sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
ThermoGenesis Holdings shares dropped 40.5% to $0.33 in pre-market trading, indicating significant negative sentiment.
The sharp decline in share price reflects strong negative sentiment, likely leading to continued downward pressure in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100